Publication | Open Access

A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways

Chemoprevention StrategyMedicineRelease FormulationPharmacologyPharmacotherapyAnti-cancer AgentPin1 Inhibitor AtraCancer TreatmentOncologyRadiation OncologyNovel TherapyMultiple Cancer Pathways